Product Program year 2020 Source: CMS Open Payments

Percepta

Device Cardiac Resynchronization Therapy - CRT

Open in the dashboard

General payments

$8,132

331 payments

Research payments

$0

0 payments

Through program year 2020, $8,132 in general payments and $0 in research payments were reported against Percepta (Cardiac Resynchronization Therapy - CRT).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $2,704 104
2019 General $5,428 227

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $7,092 306 payments
  2. Medtronic, Inc. $1,040 25 payments
Top recipients General payments · program year 2020
  1. Balaji Krishnan Clinical Cardiac Electrophysiology · St Louis Park, MN $450 17% · 1 payment
  2. Kristopher Krueger Clinical Cardiac Electrophysiology · Minneapolis, MN $450 17% · 1 payment
  3. John Lee Clinical Cardiac Electrophysiology · Lexington, KY $138 5% · 1 payment
  4. Ajay Srivastava Orthopaedic Surgery · Flint, MI $135 5% · 2 payments
  5. Thomas Crawford Clinical Cardiac Electrophysiology · Ann Arbor, MI $127 5% · 2 payments

The top 5 of 65 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $2,009 74% · 41 practitioners
  2. Cardiovascular Disease Internal Medicine $342 13% · 13 practitioners
  3. Orthopaedic Surgery $135 5% · 1 practitioner
  4. Interventional Cardiology Internal Medicine $108 4% · 7 practitioners
  5. Internal Medicine $66 2% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Minnesota $900 33% · 2 recipients
  2. Texas $456 17% · 17 recipients
  3. Michigan $314 12% · 3 recipients
  4. California $208 8% · 9 recipients
  5. Florida $175 6% · 3 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

331 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record